In a cohort of MTCL (n = 50), EZH2 protein expression was compared to healthy lymph node samples (n = 10) and found to be significantly elevated in tumor tissue (tumor vs. control: median EZH2 H-score 85.0 (IQR = 115.0) vs. 30.0 (IQR = 28.0); p = 0.0063) (Figure 1C). The gene discussed is EZH2; the disease is neoplasm.